Patents by Inventor Vincenzo Perlini

Vincenzo Perlini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of &ggr;-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
    Patent number: 6770784
    Abstract: Gamma-hydroxybutryic acid amides are used in the treatment of drug addiction and especially in the treatment of alcoholism.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: August 3, 2004
    Assignee: Laboratorio Farmaceutico C.T. S.r.l.
    Inventors: Roberto Cacciaglia, Antonella Loche, Vincenzo Perlini, Lorenza Guano
  • Use of y-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
    Publication number: 20020165224
    Abstract: Gamma-hydroxybutryic acid amides are used in the treatment of drug addiction and especially in the treatment of alcoholism.
    Type: Application
    Filed: December 11, 2001
    Publication date: November 7, 2002
    Inventors: Roberto Cacciaglia, Antonella Loche, Vincenzo Perlini, Lorenza Guano
  • Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
    Patent number: 6436998
    Abstract: The present invention relates to the use of &ggr;-hydroxybutyric acid amides in the treatment of drug addiction and alcoholism, more particularly in reducing chronic alcoholics' desire for and habit of consuming alcoholic drinks and in the treatment of the syndrome of abstinence from alcohol.
    Type: Grant
    Filed: September 2, 1999
    Date of Patent: August 20, 2002
    Assignee: Laboratoric Farmaceutico C.T. S.r.l.
    Inventors: Roberto Cacciaglia, Antonella Loche, Vincenzo Perlini, Lorenza Guano
  • Thiadiazole derivatives for the treatment of depressive states
    Patent number: 5401853
    Abstract: Thiadiazole derivatives of general formula (I) ##STR1## wherein R.sub.1 is selected from the class consisting of: C.sub.1 -C.sub.10 linear or branched alkyl, benzyl, optionally substituted at the aromatic ring with one or more groups selected on their turn from the class consisting of : C.sub.1 -C.sub.20 linear or branched alkyl residues , nitro groups, halogen atoms, C.sub.1 -C.sub.20 linear or branched alkoxy, hydroxy and C.sub.2 -C.sub.20 linear or branched acyloxy groups, R.sub.2 is selected from H, C.sub.2 -C.sub.10 alkanoyl, cycloalkanoyl wherein this ring has from 3 to 10 carbon atoms, aroyl, and R.sub.3 is selected from H and C.sub.1 -C.sub.10 alkyl, for the treatment of depressive states and anxiety, a process for their preparation and relative pharmaceutical compositions containing them as the active ingredient.
    Type: Grant
    Filed: July 9, 1993
    Date of Patent: March 28, 1995
    Assignee: Laboratorio Farmaceutico C.T. S.r.l.
    Inventors: Mario Brufani, Antonella Loche, Vincenzo Perlini, Donato Pocar